Summary & Overview
CPT 5062F: Clinical Performance Measure
CPT code 5062F is a CPT-designated code with no summary provided in the source description. As a CPT code, it represents a discrete clinical or reporting element used in medical documentation and billing workflows; its national importance derives from the role CPT codes play in standardizing procedure and measure reporting across payer systems. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise explanation of what the code represents, the expected service context where available, and a synopsis of payer coverage presence. The publication also highlights where input data is missing and notes that specific benchmarking, modifier use, associated taxonomies, related codes, ICD-10 linkages, and detailed service-line mappings are not available in the provided source. This national-level summary is intended to orient coding professionals, billing staff, and policy analysts to the presence of 5062F in CPT listings and to identify gaps where further documentation or payer guidance is needed.
Billing Code Overview
CPT code 5062F has no summary available in the source description. Based on the code designation, this entry represents a performance or clinical measure recorded using the CPT coding system. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45–70-year-old individual presenting with obstructive uropathy symptoms such as flank pain, recurrent urinary tract infections, or hydronephrosis detected on imaging. The clinician evaluates history, performs a focused physical exam, orders urinalysis and renal ultrasound or CT scan that demonstrate ureteral obstruction or compromised renal drainage. The procedural workflow involves urology consultation in an ambulatory surgical center or hospital outpatient department. Pre-procedure steps include informed consent, review of imaging, basic labs (BMP, coagulation studies as indicated), and anesthesia planning (local with sedation or general anesthesia). The procedure performed addresses the obstructive lesion—examples include ureteral stent placement, endoscopic ureteral dilation, or ureteral stone removal—followed by immediate post-anesthesia recovery, brief observation for complications (bleeding, infection, pain), and discharge with follow-up instructions and imaging or clinic follow-up to assess drainage and plan stent removal if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M encounter is performed on the same day as the procedure and documentation supports separate significant work |